Clinical Trial Update: Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating selective avoidance of nodal volumes in head and neck/oropharyngeal cancer; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Head and Neck Cancer, Oropharynx Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING